Inventor
Chunhui HUANG
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes26%
C07DHeterocyclic compounds16%
C07HSugars11%
C07KPeptides11%
C07BGeneral methods of organic chemistry5%
PatentTitleYear
12,594,282Use of small molecule compounds in the treatment of diseases mediated by lung epithelial cell injury and/or vascular endothelial cell injury202612,595,262PRMT5 inhibitors202612,552,826PRMT5 inhibitors202612,365,706Macrocyclic peptides as potent inhibitors of K-RAS G12D mutant202512,173,026PRMT5 inhibitors202411,566,057Long-acting co-agonists of the glucagon and GLP-1 receptors2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2026Patents assigned to MERCK SHARP & DOHME LLC (5)· patent assignee history
2023–2026Based in US· patent location history
2025Patents assigned to AGENCY SCIENCE TECH & RES (1)· patent assignee history
2025Patents assigned to ARONICA PIETRO (1)· patent assignee history
2025Patents assigned to BOYER NICOLAS C (1)· patent assignee history
2025Patents assigned to GARRIGOU MICHAEL B (1)· patent assignee history
2026Based in CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME LLC | 5 | 2023–2026 |
| AGENCY SCIENCE TECH & RES | 1 | 2025 |
| ARONICA PIETRO | 1 | 2025 |
| BOYER NICOLAS C | 1 | 2025 |
| GARRIGOU MICHAEL B | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2023–2026 |
| CN | 1 | 2026 |